PMP22 and hereditary neuropathy with liability to pressure palsies: However, it still accounts for 7.5% of molecularly unassigned demyelinating CMT in the absence of PMP22 duplication, GJB1 mutations or MPZ mutations, as well as 1.9% of HNPP-like neuropathy of unknown genetic causes in Taiwan.